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Bacteria expressing type III secretion systems (T3SS) have
been responsible for the deaths of millions worldwide, acting as
key virulence elements in diseases ranging from plague to
typhoid fever. The T3SS is composed of a basal body, which
traverses both bacterial membranes, and an external needle
through which effector proteins are secreted. We report multi-
ple crystal structures of two proteins that sit at the tip of the
needle and are essential for virulence: IpaD from Shigella flex-
neri and BipD from Burkholderia pseudomallei. The structures
reveal that the N-terminal domains of the molecules are intra-
molecular chaperones that prevent premature oligomerization,
as well as sharing structural homology with proteins involved in
eukaryotic actin rearrangement. Crystal packing has allowed us
to construct a model for the tip complex that is supported by
mutations designed using the structure.
Currently, more than 1 million people die per annum as a
result of T3SS8-expressing enteropathogenic bacteria such as
Shigella flexneri, the causative agent of human bacillary dysen-
tery (1). The T3SS is composed of a basal body, which traverses
both bacterial membranes and an external needle through
which effector proteins are secreted (2). During infection,
secretion is activated by contact of the tip of the needle com-
plex with host cells (3) resulting in formation of a pore in the
host cell membrane that is thought to be contiguous with the
needle (4). Other effector proteins are injected through this
apparatus directly into the host cell cytoplasm (for a review,
see Ref. 5). T3SS-expressing bacteria can be classified into
distinct phylogenetic families, both at the sequence level and
by their general mechanism of infection (6). The Inv-Mxi-
Spa family express T3SS, which trigger uptake of bacteria by
non-phagocytic cells and includes S. flexneri and Burkhold-
eria pseudomallei.
Shigella spp. cause bacillary dysentery by invasion of the
colonic epithelium (7). Of the S. flexneriT3SS effector proteins,
IpaB, IpaC, and IpaD are essential for invasion (8). IpaB and
IpaC have been demonstrated to insert into the host cell mem-
brane, thereby forming the translocation pore (4). Bacteria
lacking IpaD are not only incapable of pore insertion and inva-
sion but also demonstrate impaired effector secretion control
(9). IpaD was originally proposed to form a plug in the T3SS
with IpaB (3), while more recent data have demonstrated that
its role is more complex (9). Deletions within the N-terminal
third of the molecule do not affect invasion of host cells by the
bacteria, although the insertion of IpaB/IpaC into membranes
is slightly impaired. However, even short deletions (5 residues)
in the C terminus of IpaD completely abolish the invasive phe-
notype and pore insertion (9). These observations led us to sug-
gest that IpaD may play a role in regulating insertion of the
IpaB/IpaC translocon pore from the tip of the S. flexneri needle
(9, 10). Our recent data conclusively demonstrate IpaD is at the
tip of intact T3SS embedded in the bacterialmembranes and on
isolated needles even prior to secretion induction (11). Simi-
larly, the functional homologue inYersinia pestis, LcrV, has also
recently been localized to the tip of the needle and is required
for pore formation (12).
B. pseudomallei causes melioidosis in humans, a disease
endemic in Southeast Asia and Northern Australia. This dis-
ease presents in a variety of ways from subacute and chronic
suppurative infections to a rapidly fatal septicemia (13). B.
pseudomallei infection is dependent on a T3SS, which contains
clear homologues of IpaB/C/D termed BipB/C/D (14). The
overall sequence identity between IpaD and BipD is only 26%,
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however, with most of the conserved residues residing in the
C-terminal quarter of the sequence (Fig. 1).
We have recently determined the crystal structure of MxiH,
the S. flexnerineedle subunit, and assembled amolecularmodel
of a T3SS needle by docking it into our 16 Å electron micros-
copy reconstruction of the S. flexneri needle (15, 16). As part of
an ongoing study into the interactions of the T3SS with host
cells, we have now crystallized and determined the structures of
IpaD and BipD. Their three-dimensional structures, in con-
junction with the structure of the MxiH needle and other tip
proteins such as LcrV (17), significantly increase our under-
standing of these complex biological machines.
MATERIALS AND METHODS
IpaD Crystal Structure Determination—Protein preparation
and crystallization were described previously (18). The posi-
tions of 8 selenium atoms in the SeMet-labeled crystal form 4
(CF-4) were obtained by analyzing the measured anomalous
differences using SHELXC/D (19) within the suite of computer
programs autoSHARP (20). Initial phases were calculated with
FIGURE 1. Crystal structures of IpaD and BipD. a, ribbon diagram of the structure of IpaD (residues 39 –322) colored by domain: N-domain (blue), central
coiled-coil (green), C-domain (red). b, topology diagram of IpaD, colored as in a. c, structure of BipD (residues 35–111 and 127–301) colored as in a. All figures
were produced using PyMOL (26). d, structure based sequence alignment of IpaD, SipD, and BipD using the ESPript server (30), colored according to residue
conservation. Secondary structure elements of IpaD and BipD are shown above and below the alignment respectively. The Salmonella enterica typhimurium
homologue SipD is more closely related to IpaD.
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the program SHARP (21) using the data from a native crystal
and a multiwavelength anomalous dispersion data set from a
SeMet derivative (three peak wavelength data sets and one
remote wavelength data set). Analysis of the Log-likelihood
gradient maps in SHARP revealed two more selenium sites,
which were added to the phasing job and the SHARP phases
were extended to 2.8Å by solvent flattening in SOLOMON. See
supplemental Table 1 for phasing statistics. Non-crystallo-
graphic symmetry (NCS) 2-fold averaging was carried out in
RESOLVE (22) using the positions of the selenium to calculate
an initial NCS operator. An initial helical model was built in
the program CCP4-ARP/wARP-HelixBuild (23) using these
phases, and side chains were remodelled to the IpaD sequence
in Xfit (24), using the selenium positions as sequence markers.
The 2-foldNCS operator was used to group the helices into two
monomers, and two copies of one such monomer were then
located by molecular replacement in both CF-1 and CF-2 (18)
using CCP4-PHASER (23). 6-Fold cross-crystal averaging
between the three crystal forms was performed using CCP4-
DMMULTI (23) and produced a 2.1 Å map in CF-2, which
enabled automated building inCCP4-ARP/wARP (270 residues
built, of which 227 were docked into sequence). Alternate
cycles of refinement using Buster-TNT (25) and manual
rebuilding in Xfit led to the final model in CF-2 of residues
144–314 for copy A and 133–319 for copy B. The complete
model from CF-2 was used to guide manual building of models
in CF-4 (residues 128–177, 192–260, and 273–320 in copy A
and 123–180, 188–263, and 273–320 in copy B) with a combi-
nation of molecular replacement phases and density modifica-
tion in DM and DMMULTI. Finally, the N-terminal domain of
IpaD (residues 39–130) was built in CF-1 using Buster-TNT to
model themissing atoms during the initial stages of refinement
of the incomplete structure. Once the residues defining helices
1 and 2 were built, this model was used to phase the anom-
alous differences of a mercury-soaked CF-1 crystal in CCP4-
FFT (23), and locate 2 Hg ions, which in turn were used to
improve the CF-1 phases in SHARP, followed by solvent-flat-
tening in SOLOMON to 2.8 Å. The SHARP-SOLOMON
phases were combined with the Buster-TNT phases, and 4-fold
averaging between CF-1 and CF-2 was repeated, again using
DMMULTI. These maps allowed manual building of the final
model for CF-1 of residues 39–322 for copy A and for copy B.
All pictures were generated using PyMOL (26).
BipD Crystal Structure Determination—Protein preparation
and crystallization were described previously (27). The posi-
tions of 2 platinum ions were obtained by analyzing the anom-
alous differences of a K2PtCl4 soaked derivative of the P21212
crystal form using SHELXC/D (19) in autoSHARP (20). Initial
3.0 Å phases were calculated with the program SHARP (21)
using the single isomorphous replacement with anomalous
scattering (SIRAS) method with data from a native crystal and
the platinum derivative. After addition of the data for a SeMet
derivative crystal, analysis of the Log-likelihood gradient maps
in SHARP revealed 10 selenium sites; SOLVE/RESOLVE (22)
extended thesemultiple isomorphous replacement with anom-
alous scattering (MIRAS) SHARP phases to 2.7 Å and autobuilt
and docked in sequence BipD residues 49–69, 77–95, 99–110,
128–166, 180–197, 201–212, 232–238, and 243–301 in at least
one of the two independent monomers. The autodocked
sequence and the selenium positions guided the determination
of the NCS 2-fold operator relating chains A and B, and the
NCS was then used to fill the gaps in the autobuilt model for
either chain. Finally, iterative cycles of manual building in Xfit
(24) and Buster-TNT refinement with soft NCS restraints
yielded a model for residues 35–110 and 128–301 for both
BipD molecules A and B. The P21212 model was used to solve
the C222 crystal form by molecular replacement with the pro-
gram CCP4-PHASER (23).
Structure Superposition—All structure superpositions were
carried out using the program CCP4-lsqkab (23) as follows:
IpaD onto IpaD, BipD and MxiH using superpose topology;
IpaD onto FliS (1ORJ-A), YscE (1ZW0-A), -catenin (1DOV-
A), vinculin (1RKC-A), and talin (1SJ7-A) using the residue
mapping as defined by the DALI server (28).
Sequence Alignment—IpaD was aligned with Salmonella
enterica typhimurium SipD using ClustalW (29) and with BipD
by structure superposition. The sequence alignment was sub-
mitted to the ESPript server (30) for graphical representation.
Limited Proteolysis—Pure IpaD at 1 mg/ml was incubated
with sequencing grade trypsin (Promega) in 20mMTris, pH 7.5,
150mMNaCl. Ratios of trypsin:IpaD (w/w) of 1:50, 1:100, 1:200,
1:500 and 1:5000 were prepared and incubated in a water bath
at 37 °C for 1 h. The reaction was stopped by the addition of 2
SDS-PAGE sample buffer followed by boiling for 5 min. The
samples were analyzed by SDS-PAGE and sent for N-terminal
TABLE 1
IpaD and BipD refinements statistics (program Buster-TNT)
Values for the highest resolution shell are given in parentheses.
Crystal IpaD CF-1 IpaD CF-2 IpaD CF-4 BipD CF-1 BipD CF-2
Space group (Z) P212121 (8) C2 (8) C2 (8) P21212 (8) C222 (8)
Cell parameters (Å) a  55.9, b  100.7,
c  112.0
a  77.9, b  91.5,
c  54.9
a  137.8, b  44.5,
c  100.3
a  136.5, b  89.8,
c  50.2
a  104.0, b  122.8,
c  49.2
  96.4°   108.0°
Resolution range (Å) 20.0-3.0 (3.1-3.0) 15.0-2.1 (2.2-2.1) 34.0-3.1 (3.3-3.1) 54.0-2.7 (2.9-2.7) 40.0-2.6 (2.8-2.6)
Unique reflections 12,157 22,218 9791 17,569 10,013
R (%) 0.237 (0.276) 0.190 (0.208) 0.263 (0.262) 0.218 (0.253) 0.206 (0.226)
Rwork (%) 0.235 (0.271) 0.189 (0.207) 0.262 (0.268) 0.216 (0.251) 0.203 (0.224)
Rfree (%) 0.271 (0.376) 0.216 (0.229) 0.276 (0.308) 0.259 (0.288) 0.245 (0.263)
r.m.s.d. bond lengths (Å) 0.002 0.007 0.005 0.003 0.005
r.m.s.d. bond angles (°) 0.59 1.22 0.60 0.78 0.42
Residues modeled (range) A, B: 39–322 A: 144–314 A: 128–177; 192–260; 273–320 A: 35–111; 127–301 A: 34–111; 125–302
B: 133–319 B: 123–180; 188–263; 273–320 B: 35–111; 125–301
Waters modeled 21 208 8 44 50
Non-protein molecules 1 glycerol 1 citrate, 2 boric acid
Protein Data Bank identifier 2j0o 2j0n 2jaa 2j9t 2ixr
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sequencing (Protein Characteriza-
tion Facility, Department of Bio-
chemistry, University of Oxford).
The broad-spectrum serine pro-
tease subtilisin Carlsberg from
Bacillus licheniformis (Sigma) was
added to IpaD in a 1:5000 (w/w)
ratio (enzyme:protein) and incu-
bated at 20 °C for 72 h to mimic the
conditionsunderwhichcrystals grew.
The digested protein was then
applied to a Superdex 200 (HR 10/30)
column(GEBiosciences) equilibrated
in 20 mM Tris, pH 7.5, 100 mMNaCl,
10 mM dithiothreitol. Undigested
IpaDwas applied to the same column
under identical conditions.
Tip Localization of IpaD/BipD/
IpaB and Hemolysis Assay—S. flex-
neri were grown to log phase in
tryptic soy broth according to estab-
lished protocols (31). Bacteria were
fixed to glass slides or carbon/Form-
var-coated copper grids. Mono-
clonal anti-IpaD, rabbit anti-BipD,
or rabbit anti-IpaB IgG was used to
detect IpaD (11), BipD, or IpaB
(supplemental Fig. 2), respectively.
Alexa Fluor 488 goat anti-mouse
IgG or Alexa Fluor 568 goat anti-
rabbit IgG was used to detect the
primary antibody for confocal
microscopy, while gold-labeled goat
anti-mouse IgG or anti-rabbit IgG
was used for electron microscopy.
Hemolysis assayswere performed as
described in Ref. 4.
RESULTS
Structure of IpaD and BipD—The
structure of S. flexneri IpaD was
determined at 3.0Åby SIRAS, using a
selenomethionine derivative and
cross-crystal averaging between vari-
ous crystal forms (18) (Table 1). The
electron density (Fig. 2a) allowed
building of a model for IpaD residues
39–322 (Figs. 1a and 2b). The struc-
ture of B. pseudomallei BipD was
determined at 2.8 Å by MIRAS using
K2PtCl4 and SeMet derivatives (27)
(Table 1). The electron density (Fig.
2c) allowed construction of a model
from residues 35–111 and 127–301
(Figs. 1c and 2d).
Despite sharing only 26% identity at the sequence level, the
structures of IpaD and BipD are highly homologous (r.m.s.d. 
1.6 Å over 161/283 C atoms). Both proteins are characterized
by a long helical coiled-coil formedbetween a helix at the center
of the sequence and a helix at theC terminus (Fig. 1b). Apredom-
inantly helical domain (hereafter termed the N-terminal domain)
FIGURE 2. Stereo views of IpaD and BipD electron density (a and c) and main chain traces (b and d) are
shown. The electron density is calculated with coefficients 2Fo  wFc and phases derived from the final models.
The IpaD density in a is contoured at 1.0  around residues 284 –304 in the C-terminal coiled-coil helix and the
BipD density in c around residues 154 –172 in the N-terminal coiled-coil helix. b and d show complete main
chain traces oriented so that the N and C termini are at the bottom of the picture.
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precedes the first helix of the central coiled-coil, while the
sequence encoding a mixed - domain (hereafter termed the
C-terminal domain) is inserted between the two long helices of
the coiled-coil. Two helices from
the N-terminal domain (named 1
and 2, see Fig. 1b) fold against one
end of the coiled-coil, while two hel-
ices from the C-terminal domain
(4 and 6) pack against the other
end of the coil. Both molecules
therefore comprise two four-helix
bundles that share the long coiled-
coil. In addition, the N-terminal
domain of IpaD contains a helical
insertion relative to BipD between
2 and 3, which wraps around the
end of the coiled-coil, while BipD
contains a less structured insertion
relative to IpaD between 1 and 2.
In both IpaD and BipD, the C-ter-
minal domain is embellished by a
three-stranded anti-parallel -sheet
at the very end of the coil and an
insertion of a short -helix (5) and
two -strands (C, D) between 4
and 6 of the bundle. Despite the
conserved topology, the relative ori-
entation of 5-C-D compared
with the rest of the molecule differs
between IpaD and BipD. The C-ter-
minal residues are not visible in any
of the structures. These are the res-
idues that have been demonstrated
to be essential for binding of IpaD to
the tip of the S. flexneri needle (11).
Disordered termini have been
observed in other T3SS (32) and
flagellar filament (33) molecules
and this feature has been proposed
to be important in correct assembly
of these structures (33).
N-terminal Domain as Chap-
erone—The N-terminal four-helix
bundle of IpaD/BipD shows strong
structural homology with chaper-
ones of T3SS filament-forming pro-
teins (DALI (28)). The strongest hit
(Z-score 11.0) is the flagella chap-
erone FliS (Fig. 3a), a four-helix
bundle that prevents premature
assembly of the flagellumby binding
the C-terminal helix of FliC (34). A
DALI search using the N-terminal
domain of IpaD alone retrieved YscE
(35), the putative chaperone of the Y.
pestis needle component YscF (Fig.
3b). In addition, the structure of
CesA, the chaperone of EspA (a pro-
teinwhich formsahelical filament extension to theT3SSneedle of
enteropathogenicEscherichia coli) is also reminiscent of the IpaD/
BipDN-terminal domain (32).
FIGURE 2— continued
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During the initial crystallization trials of IpaD we observed a
crystal form which grew over a long period of time that was
shown byN-terminal sequencing to consist of a truncated form
of the protein (18). Incubation of IpaD with increasing concen-
trations of trypsin resulted in a gradual degradation to a prote-
ase resistant core (Fig. 4a) identified by N-terminal sequencing
to start at Ile138. The proteolytic sensitivity of the N-terminal
domain of IpaD is in agreement with our earlier biophysical
characterization of IpaD which demonstrated that the N-ter-
minal domain unfolds at lower temperatures and independ-
ently of the rest of the molecule (36).
To date, no specific chaperones for IpaD or BipD have been
identified. Our data suggest that the role of the N-terminal
domain of IpaD/BipD is to chaperone residues on the coiled-
coil involved in interactions with the needle and/or itself.
Removal of the N-terminal domain in silico results in the expo-
sure of 2100 Å2 of solvent-accessible surface area (37), includ-
ing a hydrophobic strip that runs along the face of the two
-helices of the coiled-coil (Fig. 4b). Removal of theN-terminal
domain of BipD exposes an even more extended patch (2300
Å2). All crystals grown with N-terminally truncated IpaD pack
in such a way as to bury this patch in crystal contacts. Further-
more, proteolytic removal of the N-terminal domain of IpaD
leads to oligomerization in solution. Full-length IpaD elutes
as an 50-kDa protein during size exclusion chromatogra-
phy (Fig. 4c). Subtilisin treatment, which clips the N-termi-
nal third of the molecule (18), leads the truncated form to
elute as an 115-kDa protein, a size consistent with the
formation of a tetramer or pentamer.
In addition, the helices of the coiled-coil seem to be con-
strained by the N-terminal domain (Fig. 4d). In the presence of
the N-terminal domain, the coiled-
coil is rigid and invariant between
the two crystallographically inde-
pendent molecules in the intact
IpaD crystals and the three inde-
pendent molecules seen in the BipD
crystals. In the absence of the N-do-
main, however, the coiled-coil
acquires flexibility, as demonstrated
in the four crystallographically
independent truncated IpaD mole-
cules. These results represent the
first examples of T3SS molecules
self-chaperoning.
IpaD/BipD and Actin Reprogram-
ming—Three of the top five hits
against the DALI data base using
IpaD/BipD as a search model are
proteins involved in rearrange-
ments of the actin cytoskeleton;
talin (38) (Z-score 10.8, r.m.s.d.
2.2 Å over 111 C atoms), vinculin
(39) (Z-score  10.1, r.m.s.d.  2.3
Åover 106C atoms) and-catenin
(40) (Z-score  9.0, r.m.s.d.  3.9 Å
over 158 C atoms) (supplemental
Fig. 1). Furthermore, like IpaD/
BipD, these structural homologues are proteins that are char-
acterized by multiple helical bundles which are capable of hel-
ical rearrangement. This is significant as bacteria of the
Shigella/Salmonella family cause membrane ruffling by actin
re-arrangement to invade non-phagocytic cells. A possible role
for IpaD/BipD in interfering with host cell actin is examined
under “Discussion.”
IpaD/BipD at the Tip of the Needle—We have recently pro-
posed a model by which LcrV, the functional homologue of
IpaD/BipD in Y. pestis, may oligomerize at the tip of the needle
based on homologies between the LcrV and MxiH structures
(16). However, althoughwe can immunolabel IpaD on the tip of
the S. flexneri needle (11), we have been unable to directly visu-
alize a S. flexneri tip complex. This is not surprising asmodeling
of IpaD/BipD onto the needle in an analogous way to the LcrV
results in a structure that would be difficult to visualize at the
resolution of our current images, appearing as an extension to
the needle, compared with the more bulky LcrV tip (data not
shown).
Despite this, one of the IpaD crystal structures (CF-2) does
point toward a possible arrangement of IpaD/BipD at the tip.
The crystal, which diffracted to 2.1 Å, contains a tightly packed
dimer (Fig. 5a) in which the two copies of the molecule in the
asymmetric unit are related by a rotation of 72.2° around the
long axis of the molecule and a rise of 4.6 Å, comparable with
the parameters defining the 1-start helix of the MxiH needle
(16). This dimer buries 1500 Å2 (14%) of the solvent-accessible
surface area of each IpaD monomer (37), including the hydro-
phobic strip that runs along the length of the coiled-coil, and
contains two inter-molecular salt bridges (Lys-151-Glu-229
FIGURE 3. The N-terminal domain is a chaperone. a, ribbon diagram of IpaD (green) superposed on Aquifex
aeolicus FliS (purple, 1ORJ-A (r.m.s.d.  2.0 Å over 103 C atoms) (39). b, ribbon diagram of IpaD (green) super-
posed on Y. pestis YscE (light blue, 1ZW0-A, r.m.s.d.  1.8 Å over 57 C atoms) (35). c, ribbon diagram of IpaD
(green) superposed on Bacillus subtilis FliS (purple, 1VH6) demonstrating the opened four-helix bundle.
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and Glu-154-Lys-300) involving residues that are solvent
exposed in the full-length monomer.
The residues involved in forming this contact are clustered in
theC-terminal helix, with one face providing half of the binding
pocket for another face of the same helix from a neighboring
monomer (Fig. 5b). These residues are the most conserved res-
idues in the Shigella/Salmonella family of tip proteins (Fig. 1d).
By superposing molecule A onto molecule B, and then again in
an iterative fashion, it is possible to build a tightly packed pen-
tamer, which buries all of the hydrophobic surfaces in the mol-
ecule (Fig. 5c). This pentamer buries 3000 Å2 (28%) of the sol-
vent-accessible surface area of each monomer. Furthermore,
the arrangement places the N-terminal helix of the coiled-coil
on the outside of the pentamer, thereby allowing theN-domain
to be positioned outside of the needle. Supporting the physio-
logical relevance of these interactions, a double mutation that
destroys the two salt bridges involved in the pentamer forma-
tion (K151E; E154K) reduces the
hemolytic activity to 55.3  3.6% of
that of the wild type bacteria.
One major consequence of the
formation of this pentamer is the
fact that it is closed, i.e. there is no
hole through the center of the struc-
ture. This is consistent with the ear-
lier observations that bacteria lack-
ing IpaD secrete the later effector
proteins constitutively (3). How-
ever, the observation in the same
study that bacteria lacking IpaB dis-
play the same phenotype, combined
with data showing surface localiza-
tion of IpaB (41), led to the proposal
that IpaD and IpaB form a plug
together in the needle (3). Subse-
quent studies have demonstrated
IpaB decorates the surface of S. flex-
neri in a punctate pattern (42) and is
associated with the tips of purified
needles.9,10 Although there is cur-
rently no atomic model of IpaB, it is
predicted to contain two long
coiled-coil regions, the first from
residues 130–170 and the second at
the extreme C terminus (residues
530–580) (43).Wepredict that IpaB
has a similar fold to IpaD/BipD,
with an internal coiled-coil but with
a much larger C-terminal domain.
Due to the helical rise of the penta-
mer, the interface between the fifth
and the first molecule is different to
that between the other consecutive
pairs of monomers, and therefore it
is possible that the final position of
the pentamer is filled by IpaB. This
would explain the need for both
IpaD and IpaB to properly control
secretion, with four copies of IpaDpolymerizing at the tip of the
needle and one molecule of IpaB locking the structure.
To test this hypothesis, we first investigated the presence of
IpaD and IpaB at the tip of the needle. Using a variety of tech-
niques, including immunofluorescence (supplemental Fig. 2)
and electron microscopy (data not shown), we were able to
observe both IpaDand IpaB at the surface ofwild type S. flexneri
(Table 2). Surface-localized IpaB was dependent on the pres-
ence of IpaD (Table 2), while IpaD was still surface-localized in
the absence of IpaB (11). This suggests that IpaD is able to
directly bind the MxiH needle, while IpaB requires a binding
surface that involved residues on IpaD.
Based on the structure of the IpaD monomer, we designed
mutants to cleanly remove the N-terminal (41–130) and C-ter-
9 A. J. Blocker, submitted for publication.
10 W. L. Picking, submitted for publication.
FIGURE 4. Consequences of removal of the N-terminal domain. a, proteolytic sensitivity of the N-terminal
domain of IpaD. IpaD was incubated with trypsin at various ratios (w:w), and the resulting digests were resolved
on SDS-PAGE. Band 1 (24 kDa) begins at residue 120 and Band 2 (20 kDa) at residue 138. b, surface represen-
tation of IpaD39 –130 (left) and IpaD131–322 (right) with hydrophobic residues colored green and brown, respec-
tively. IpaD39 –130 is rotated through 180° along the long axis relative to IpaD131–322 to demonstrate the com-
plementary hydrophobic surfaces. The surface is presented as transparent to allow visualization of the
secondary structure. c, analytical gel filtration chromatography (Superdex 200, HR 10/30) of IpaD before and
after subtilisin treatment. Elution volume of each species is noted along with the Mr calculated from SDS-PAGE.
d, overlay of five structures of the IpaD coiled-coil demonstrating the flexibility of the helices in the absence of
the N-terminal domain. The conformation of the coil in the presence of the N-terminal domain is shown in
green. The C-terminal domain has been removed to aid clarity.
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minal (192–267) domains and
assessed their ability to complement
an ipaD mutant. Removal of the
N-terminal domain did not affect
the binding of either IpaD or IpaB at
the tip of the needle, consistent with
its role as a chaperone. Removal of
the C-terminal domain, on the
other hand, completely abolished
binding of IpaB at the tip, without
affecting localization of IpaD (Table
2). This is consistent with the het-
ero-pentamer model proposed, as
theC-terminal domain of IpaD does
not contribute significantly to the
IpaD-IpaD interaction (as assessed
using the MSDpisa server (37)). In
contrast, it would likely be involved
in binding of the much larger IpaB
molecule. The result, therefore,
highlights an essential role for the
IpaD C-terminal domain in binding
the IpaB molecule. In further sup-
port of this, BipD could also be visu-
alized on the surface of S. flexneri
when expressed in an ipaD
mutant, but IpaBwas unable to bind
(Table 2).
DISCUSSION
Here we present the first struc-
tures of T3SS needle tip proteins
from the Shigella/Salmonella fam-
ily, which trigger uptake of the bac-
teria by non-phagocytic cells. The
structures of IpaD andBipD, from S.
flexneri and B. pseudomallei,
respectively, are homologous, con-
sisting of a central coiled-coil with a
domain at either end. The struc-
tures demonstrate the first exam-
ples of self-chaperoning within
T3SSmolecules andhave allowedus
to construct a model for a needle tip
complex of S. flexneri. Furthermore,
we have been able to attribute dif-
ferent functions to distinct domains
within the proteins.
IpaD has recently been shown to
exist at the tip of the MxiH needle
(11), from where it appears to
orchestrate the correct insertion of
FIGURE 5. Oligomerization of IpaD. a, ribbon diagram of the non-crystallographic dimer found in crystal form
2 (18). Molecule A is shown in green and molecule B in blue. b, detailed view of the dimer interaction site with
side chains displayed, colored as in a. Only structural elements that contribute to the binding site are displayed
for clarity. c, pentamer produced using the non-crystallographic symmetry from crystal form 2. At the top are
ribbon representations and at the bottom surface views. The panels on the left are related to the panels on the
right by a rotation of 90°.
TABLE 2
Needle-tip localization of IpaD and IpaB
Wild type IpaD ipaD/IpaD41–130 IpaD/IpaD192–267 ipaD/BipD
IpaD/BipD at needle-tip     
IpaB at needle-tip     
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the IpaB/C translocon into host cell membranes (9). The struc-
tures of two other needle tip proteins from distinct T3SS fam-
ilies are known: LcrV from Y. pestis (17) and EspA from enter-
opathogenic E. coli (32). Both of these molecules also contain a
central coiled-coil, but in other aspects there are few structural
similarities with IpaD/BipD, especially at the N terminus of the
molecules. These structures, combined with our recent needle
subunit structure (16) and the structures of the polymerizing
components of the bacterial flagellum (44), serve to highlight
the importance of intramolecular helical coiled-coils as scaf-
folds for superhelical assemblies while emphasizing that spe-
cific functions can be “bolted onto” the assembly in the form of
structurally distinct domains.
Most T3SS proteins are chaperone-bound within the bacte-
rial cytoplasm. Chaperones are thought to play multiple roles
both in directing T3SS proteins to the base of the apparatus for
export and also in preventing premature assembly of structural
components (45). For example, EspA interacts with CesA in the
bacterial cytoplasm, while LcrV seems to be chaperoned by
LcrG since expression of LcrV in the absence of LcrG leads to
oligomerization of LcrV (46). Although no structure of LcrG is
available, the protein is predicted to be -helical and to interact
with the central coiled-coil of LcrV with 1:1 stoichiometry (46).
Based on our structural and biochemical data, we propose
that the most complete models of IpaD and BipD found in our
crystals represent the form of the molecule present in the bac-
terial cytoplasmand that the role of theN-terminal domain is to
chaperone residues on the coiled-coil involved in interactions
at the tip of the needle. The proteins would be partially
unfolded during export through the needle (16) and would
refold at tip of the needle into an alternate conformation with
the N-terminal domain pointing away from the coiled-coil.
This would require that the interactions formed at the tip of the
needle are more favorable than the interactions between the
N-terminal domain and the coiled-coil. In this context, it is
noteworthy that two structures for FliS, the closest IpaD/BipD
structural homologue, have been determined that are related by
opening of the four-helix bundle and rotation of one pair of
helices with respect to the other (1ORJ and 1VH6) (Fig. 3c).
Removal of the N-terminal domain of IpaD by proteolysis
also resulted in increased flexibility of the coiled-coil. Such
flexibility of the coiled-coil appears to be a common feature
of needle and tip proteins and may be of importance in sig-
naling. Our MxiH crystal structure revealed two conforma-
tions of the molecule, related by a hinging motion part way
down the coiled-coil (16), while LcrV has a significant kink in its
C-terminal helix (17), whichmatches the kink in one of theMxiH
conformations. EspA, on the other hand, contains a straight
coiled-coil, as seenwhen itwascrystallizedboundto its chaperone,
which would likely limit the flexibility of the helices (32). By
removing theN-terminal domain of IpaDwe appear to have crys-
tallographically trapped the coiled-coil in a number of states
between the extremes of LcrV and EspA.
The IpaD and BipD structures represent the first examples of
self-chaperoning T3SSmolecules. Amajor question, therefore,
is why they have adopted the strategy of incorporation of the
chaperone into the polypeptide chain, while other T3SS fila-
ment-forming proteins maintain separate chaperones. It is
tempting tospeculate that fusionof thechaperone to therestof the
molecule allows for greater flexibility of function within a single
polypeptide chain. Intriguingly, given themechanism of infection
employed by the Shigella/Salmonella family, three of the top five
structural homologues of the N-terminal half of IpaD/BipD are
proteins involved in the re-arrangement of the actin cytoskeleton.
Given that S. flexneri secretes large amounts of IpaD upon activa-
tion, significant quantities may translocate into the host cell cyto-
plasm, where it would be free to refold into the bacterial cytoplas-
mic form and co-operate with other effector molecules in the
re-programming of the cytoskeleton. It is worth noting that a
domain of SipA, an actin-binding Salmonella effector molecule
homologous to IpaA is also a structural homologue of vinculin
(47), while a recent crystal structure of vinculin bound to a helix of
IpaA has demonstrated that S. flexneri effectors do indeed utilize
molecular mimicry during infection (48).
The key role for IpaD occurs at the tip of the needle, where it
is essential for mediating correct insertion of the IpaB/IpaC
translocon into host cell membranes (9, 11). We propose a
model for an IpaD/IpaB hetero-pentamer at the tip of theMxiH
needle, based on crystal contacts in one of the crystal forms.
This model involves export of four copies of IpaD to the tip of
the needle, where they pack into the needle via the C-terminal
residues. Finally, a copy of IpaB slots into the pentamer via its
central coiled-coil, thereby locking the pentamer and prevent-
ing further secretion of other effectors. Thismodel is consistent
with the helical parameters of the MxiH needle and with the
published null mutant phenotypes of S. flexneri (8). Mutations
designed based on the structure of IpaD are wholly consistent
with themodel and demonstrate that the C-terminal domain of
IpaD is critical for binding of IpaB at the needle tip. The small
amounts of effector proteins secreted in the absence of activa-
tion, termed “leakage,” could be explained by needles that have
not fully assembled the IpaD/IpaB plug, by premature loss of
IpaD/IpaB from the tip, or by a “breathing” of the struc-
ture between a closed and open state. In addition to closing the
needle, this model would also position the predicted large
C-terminal domain of IpaB as the most distal point from the
needle and therefore the likely point of contact with the host
cell. The C-terminal domain of IpaB contains two predicted
trans-membrane helices and, significantly, the top hit when
searching the ProteinDataBankwith its sequence (FFASServer
(49)) is Colicin B, a bacterial pore-forming toxin, which utilizes
a helical trans-membrane hairpin (50). Activation of the tip com-
plex, by contact with the host cell, could trigger a conformational
change leading to anopening of the pentamer, possibly into a con-
formationmore similar to our earliermodel of LcrVat the tip (16).
This would open the channel to allow export and assembly of the
pore components IpaB and IpaC into the host cell membrane,
thereby triggering the infectious process.
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Note Added in Proof—The structure for another crystal formof BipD
has recently been published (Erskine, P. T., Knight, M. J., Ruaux, A.,
Mikolajek, H., Wong Fat Sang, N., Withers, J., Gill, R., Wood, S. P.,
Wood, M., Fox, G. C., and Cooper, J. B. (2006) J. Mol. Biol. 363,
125–136). The structure revealed is consistent with those presented
herein. The authors do not discuss a role for BipD at the tip of the
T3SS needle; however, they propose that their crystallographic
dimer has biological relevance. Their dimer is not observed in any of
our IpaD or BipD crystals and is constructed from a head-to-tail
arrangement (incompatible with assembly at the tip of the needle).
Our model for IpaD at the tip is also supported by recent 2D projec-
tion images of IpaD at the Shigella needle tip (Sani, M., Botteaux, A.,
Parsot, C., Sansonetti, P., Boekema, E. J., and Allaoui, A. (2006) Bio-
chem. Biophys. Acta doi:10.1016/j.bbagen.2006.10.007).
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Supplementary Table 1. IpaD and BipD experimental phasing statistics (program 
SHARP) 
 
Phasing IpaD SIRAS BipD MIRAS 
Dataset Native SeMet (pk) Native K2PtCl4 SeMet 
Resolution (Å) 43.0-2.8 34.0-3.4 54.0-2.7 33.0-3.0 44.0-3.3 
Wavelength (Å) 0.9757 0.9792 0.9330 0.9330 0.9794 
Heavy atom sites - 10 Se - 2 Pt 10 Se 
Phasing 
Power 
(iso) 
Centrics - 34.0-4.5 Å: 0.587 
34.0-3.4 Å: 0.609 
- 33.0-4.5 Å: 1.166 
33.0-3.0 Å: 0.597 
44-4.5 Å: 1.358 
44-3.3 Å: 0.777    
 Acentrics - 34.0-4.5 Å: 0.365 
34.0-3.4 Å: 0.458 
- 33.0-4.5 Å: 1.061 
33.0-3.0Å: 0.706  
44-4.5 Å: 1.218 
44-3.3 Å: 0.848 
Phasing Power (ano)  
      
- 34.0-4.5 Å: 2.210 
34.0-3.4 Å: 2.064 
 
- 33.0-4.5 Å: 1.803 
33.0-3.0Å: 0.787 
 
44-4.5 Å: 0.660 
44-3.3 Å: 0.345 
Acentrics FOM 
                  
34.0-4.5Å: 0.715 
34.0-3.4 Å: 0.560 
44-4.5 Å: 0.493 
44-3.3 Å: 0.218 
Centrics FOM 
           
34.0-4.5Å: 0.366 
34.0-3.4 Å: 0.283 
44-4.5 Å:0.438  
44-3.3 Å:0.245 
 
1 
  
 
Supplementary Figure 1. Structural homologies with actin-binding proteins. (a) Ribbon 
diagram of IpaD (green) overlayed on Mus musculus Talin residues 482-655 (yellow-orange, 
1SJ7-A, rmsd = 2.2 Å over 111 Cα atoms). (b) Ribbon diagram of IpaD (green) overlayed on 
Homo sapiens Vinculin residues 1-258 (sand, 1RKC-A, rmsd = 2.3 Å over 106 Cα atoms). 
(c) Ribbon diagram of IpaD (green) overlayed on Mus musculus α-Catenin dimerization 
domain (pink, 1DOV-A, rmsd = 3.9 Å over 158 Cα atoms). 
 
Supplementary Figure 2. Detection of IpaB on the surface of Shigella flexneri in a punctuate 
pattern using Immunofluorescence as described in the main text (Methods). (a) When an ipaB 
null mutant is treated with rabbit anti-IpaB antiserum/Alexa fluor 568-conjugated goat anti-
rabbit IgG no IpaB is visualised on the cell surface  (b) Whereas in the wild type cells the 
same treatment detects IpaB on the cell surface  (c) and (d) Differential interference contrast 
micrograph of panels (a) and (b) respectively. 
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